Table 4.
Kidney Disease/Disorder | Exosome’s Role | Exosome’s Source | Main Findings |
---|---|---|---|
Renal cell carcinoma (RCC) | Therapeutics | RCC cell line Pathogenic |
CD8 + T-cells activated by exosomes generated from RCC cells combined with GM-CSF and IL-12 showed autologous anti-cancer activity. |
Biomarker | Urine (human) | Urinary exosomal miR-126-3p in combination with miR-449a or miR-34b-5p might distinguish ccRCC from healthy people. Urinary exosomal miR-126-3p in combination with miR-486-5p in urine might distinguish ccRCC from benign tumors. |
|
Kidney stone disease | Pathogenic | Urine (human) | Urinary exosomes were produced in larger quantities by stone formers. |
Renal fibrosis | Therapeutics | MSCs (human) | Exosome miR-let7c generated from MSCs has reduced fibrosis in renal tubular epithelial cells. |
Polycystic kidney disease | Pathogenic | Urine (human) | Multiple PKD-related gene products were excreted into the urine via exosomal secretion. |